Cat. No. 5808
Chemical Name: 5-(Dimethyl-1,2-oxazol-4-yl)-2-[2-(
Biological ActivityNegative control for PF CBP1 (Cat. No. 5801). Exhibits negligible activity at CBP and BRD4.
Licensing InformationSold for research purposes under agreement from Pfizer Inc.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Chekler et al (2015) Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem.Biol. 22 1588. PMID: 26670081.
If you know of a relevant reference for ISOX INACT please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses ISOX INACT from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: ISOX INACT, supplier, ISOXINACT, negative, control, PFCBP1, bromodomains, CBP, BRD4, Tocris Bioscience, Bromodomain products
Find multiple products by catalog number
New Products in this Area
Histone H3 peptideTC AC 28
High affinity BET bromodomain ligandTP 472N
Negative control for TP 472 (Cat. No. 6000).TP 472
Potent BRD9/7 inhibitorBAY 299
Potent and selective BRD1 and TAF1 inhibitor
Follow Tocris on LinkedIn
Visit our LinkedIn page for the latest Tocris news, events and updates.